Sarepta Stock Soars After FDA Says It Can Resume Drug Shipments - Investor's Business Daily
Sarepta stock soared after the FDA said the biotech company can resume shipments of a controversial gene therapy drug.
Search Group
Share To
Comments
About Screade
Screade® Inc. version 125d372, copyright 2016 - 2025
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments